• Lion won the local rights to Corona after SABMiller acquired Foster’s.
    Lion won the local rights to Corona after SABMiller acquired Foster’s.
Close×

Local brewers are pondering the ramifications as Belgium beer giant Anheuser-Busch InBev pursues its rival SABMiller to create a global $382 billion beer colossus.

Though the deal has yet to gain regulatory approval, should it proceed, onlookers say there will be fallout in Australia.

SABMiller owns Carlton & United Breweries (CUB), and if the takeover proceeds, some have predicted Lion may lose its exclusive local distribution rights to AB InBev brands such as Corona, Stella Artois and Beck’s to CUB.

Lion won the local rights to Corona, one of Australia’s biggest selling beers, after SABMiller acquired Foster’s a few years ago.

Lion chief Stuart Irvine says he not yet been in touch with AB InBev to discuss the ramifications.

“We have not been specifically in touch with them because there is no need to, because we are just controlling what we need to control,’’ Irvine told The Australian this week.

Meanwhile, Dr Tim Cooper, the managing director of Australian family owned Coopers Brewery, which accounts for five per cent of the Australian beer market, said the possible acquisition of SABMiller by AB InBev had been rumoured for more than a year, and its impact would be felt locally.

“It will place significant additional pressure on the brewing industry suppliers going forward and result in a further loss of diversity,” he said.

“However, Coopers remains fiercely independent.”

Packaging News

Pact Group will delist from the ASX on Wednesday 16 July, the move being the culmination of executive chair and owner Raphael Geminder’s near two-year bid to take full control of the company.

Packaging is at the heart of Suntory’s bold new chapter in Australia, marked by the opening of its $400 million beverage production facility in Swanbank, Queensland – a site purpose-built to deliver high-speed, high-efficiency bottling, canning and kegging through world-class packaging technology and sustainable design.

Ego Pharmaceuticals has unveiled a bold new chapter in its commitment to local manufacturing, announcing a $156 million, decade-long investment to expand its Victorian operations.